- About Us
- Why Partner
-
Pipeline
- Marketed Products
- Priligy®
- Nesina®
- Oseni® and Liovel®
- Kazano®
- Discovery/Development
Pipeline - Eluxadoline (MuDelta)
- Novel Fluoroquinolone JNJ-Q2
- SYR-472
Trelagliptin
- Investors
- News
- Contact
Furiex Pharmaceuticals, Inc. is a drug development collaboration company using innovative clinical development strategies to accelerate and increase the value of partnered drug programs by advancing them to the market in a cost-efficient manner.
EXPERT. FOCUSED. FAST.
07 May >> Furiex Reports First Quarter 2013 Financial Results
Listen to webcast
More details >
09 Apr >> Furiex Pharmaceuticals Announces First Quarter 2013 Earnings Release and Conference Call More details >
04 Apr >> Furiex Pharmaceuticals to Receive Milestone Payment for Priligy® Launch in France More details >